Thursday March 23, 2023
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International US West
    • |BioProcess International Europe
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Biosimilars
    • Cell/Gene Therapies
    • Continuous Bioprocessing
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Fill/Finish
    • Formulation
    • Information Technology
    • MAb
    • Manufacturing Contract Services
    • Personalized Medicine
    • Process Monitoring and Controls
    • Single Use
    • Supply Chain
    • Vaccines
    • Validation
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

Regulatory Affairs

Perspective on the US Position on Comparability and Its Implications for Generic Biotech Products

by BPI Contributor
May 1, 2003

On Problem Investigations (Part 2)

by BPI Contributor
May 1, 2003

On Problem Investigations (Part 1)

by BPI Contributor
April 1, 2003

So What Are GMPs, Anyway?

by BPI Contributor
February 1, 2003

Glossary of International Biotherapeutic Regulation

by BPI Contributor
February 1, 2003

Establishing Resin Lifetime

by BPI Contributor
January 1, 2003
  • <
  • 1
  • ...
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26

  • BioProcess Insider

    Thermo Fisher cutting jobs at single-use sites in Utah

  • BioProcess Insider

    Pfizer to acquire Seagen for $43 billion

  • Sponsored Content

    Microplate Based Assay for Misparing of Bispecifics in Cell Culture Samples

  • BioProcess Insider

    GenSight gene therapy delay due to operation issue at CDMO Thermo Fisher

  • BioProcess Insider

    Seagen on rumored Pfizer deal: ‘It’s all noise, until it isn’t’

  • Sponsored Content

    Enabling Real-Time Process Control: Automated Glucose Feeding Based on Online Measurement


Bispecific Antibodies Conference

Recent Tweets

  • Tweet Avatar The March 2023 issue of BioProcess International is now available in print and digital! Click the link below to re… https://t.co/poDqexPlZX 1 hour ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Advances in Bioanalytical Tools for the Characterization of In-Process Vi… https://t.co/gnQoZfbTFO 1 day ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "MAb Purification Process Development Using Mixed-Mode Resins — The DOE Ap… https://t.co/U1ezWd3Qn2 6 days ago
  • Tweet Avatar Please join us today for a #BPIAskTheExpert on "Advantages of Mixed-Mode Chromatography in Host Cell Protein Remova… https://t.co/KhZ2OiiFZN 6 days ago
Follow @bioprocessintl

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2023 BioProcess International All Rights reserved
  • Home
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International US West
    • BioProcess International Europe
  • BioProcess International Academy
  • Events